Home
/
Orchestra BioMed Holdings, Inc.
/
Financials
/
Quarterly
Orchestra BioMed Holdings, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Orchestra BioMed Holdings, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$861.0K
Nov 10, 2025
Q2
2025
Jun 30, 2025
$836.0K
Aug 12, 2025
Q1
2025
Mar 31, 2025
$868.0K
May 12, 2025
Q3
2025
Sep 30, 2024
$987.0K
Nov 10, 2025
Q2
2025
Jun 30, 2024
$778.0K
Aug 12, 2025
Q1
2025
Mar 31, 2024
$620.0K
May 12, 2025
Q3
2024
Sep 30, 2023
$419.0K
Nov 12, 2024
Q2
2024
Jun 30, 2023
$915.0K
Aug 12, 2024
Q1
2024
Mar 31, 2023
$1.16M
May 13, 2024
Q3
2023
Sep 30, 2022
$1.16M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$401.0K
Aug 10, 2023
Q1
2023
Mar 31, 2022
$866.0K
May 12, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($20.83M)
Nov 10, 2025
Q3
2025
Jun 30, 2025
($19.36M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($19.36M)
Aug 12, 2025
Q2
2025
Mar 31, 2025
($18.76M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($18.76M)
May 12, 2025
Q3
2025
Mar 31, 2025
($18.76M)
Nov 10, 2025
Q3
2025
Sep 30, 2024
($15.43M)
Nov 10, 2025
Q3
2025
Jun 30, 2024
($15.98M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($15.98M)
Aug 12, 2025
Q3
2025
Mar 31, 2024
($13.46M)
Nov 10, 2025
Q2
2025
Mar 31, 2024
($13.46M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($13.46M)
May 12, 2025
Q3
2024
Sep 30, 2023
($13.32M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($12.05M)
Aug 12, 2024
Q3
2024
Jun 30, 2023
($12.05M)
Nov 12, 2024
Q3
2024
Mar 31, 2023
($10.94M)
Nov 12, 2024
Q1
2024
Mar 31, 2023
($10.94M)
May 13, 2024
Q2
2024
Mar 31, 2023
($10.94M)
Aug 12, 2024
Q3
2023
Sep 30, 2022
($10.28M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($7.85M)
Aug 10, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($20.31M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($19.33M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($18.92M)
May 12, 2025
Q3
2025
Sep 30, 2024
($16.34M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($16.86M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($14.42M)
May 12, 2025
Q3
2024
Sep 30, 2023
($14.52M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($12.96M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($11.55M)
May 13, 2024
Q3
2023
Sep 30, 2022
($10.07M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($7.63M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($5.13M)
May 12, 2023
Q3
2022
Sep 30, 2021
($94.4K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($96.3K)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($111.9K)
May 13, 2022
Q3
2021
Sep 30, 2020
($68.6K)
Mar 31, 2022
Q2
2021
Jun 30, 2020
($15.2K)
Aug 16, 2021